The Effects of Transcutaneous Electrical Nerve Stimulation (TENS)on Pain and Agitation

The Effects of Transcutaneous Electrical Nerve Stimulation (TENS) in Acupuncture Points (Hegu and Zusanli) on Pain and Agitation Reduction under Ventilator ICU Patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016050927819N1

Enrollment

Registered

2017-02-10

Start date

2017-02-19

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Agitation. Condition 2: Pain. Irritability and anger Pain, not elsewhere classified

Interventions

Intervention 1: TENS devices active: Case group TENS electrodes are placed on points Hego and zosunli .Then the TENS is turned on with frequency 1-10 Hz and 20-50 mA to using for 30 minutes three ti

Treatment - Devices

TENS devices active: Case group TENS electrodes are placed on points Hego and zosunli .Then the TENS is turned on with frequency 1-10 Hz and 20-50 mA to using for 30 minutes three times a day. pain

TENS device disabled: control group TENS electrodes are placed on points Hego and zosunli . Then the TENS is turned off to using for 30 minutes three times a day. pain and agitation severity is me

Eligibility

Sex/Gender

All

Age

30 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Having endotracheal tube; Pneumonia patients requiring mechanical ventilation; aged 30 to 50; Placement of electrodes is healthy skin; Blood pressure> 100Hg; Non-zero score on scale of COPT; Non-zero score on scale of Richmond; No smoking or narcotic; New Admission in ICU; 10)GCS>7 Exclusion criteria: Conditions prohibiting the use of TENS (such as pacemakers, because of the unknown effects of TENS on electrical conduction system or placing the electrode directly on open wounds); Obesity (weight more than 100 pounds); Skin infection or severe skin disease in the place of the electrodes; Pregnancy

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: Per 2 hours untill two day. Method of measurement: using the scale of Critical-Care Pain Observation Tool(CPOT).;Agitation. Timepoint: Per 2 hours untill two day. Method of measurement: using the scale of Richmond.	—

Secondary

Measure	Time frame
The amount of Narcotic used. Timepoint: 48 hourse. Method of measurement: microgram.;The amount of sedation used. Timepoint: 48 hourse. Method of measurement: miligram.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRasool Kaviannezhad

Kermanshah University of Medical Scienes

r.kaviannezhad@kums.ac.ir+98 83 3827 9697

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026